A detailed history of Ubs Group Ag transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Ubs Group Ag holds 3,281 shares of SMTI stock, worth $112,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,281
Previous 1,439 128.01%
Holding current value
$112,210
Previous $40,000 147.5%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$26.86 - $35.89 $49,476 - $66,109
1,842 Added 128.01%
3,281 $99,000
Q2 2024

Aug 13, 2024

SELL
$27.85 - $36.45 $72,967 - $95,499
-2,620 Reduced 64.55%
1,439 $40,000
Q1 2024

May 13, 2024

SELL
$33.72 - $40.94 $11,195 - $13,592
-332 Reduced 7.56%
4,059 $150,000
Q4 2023

Feb 09, 2024

BUY
$26.33 - $41.6 $55,924 - $88,358
2,124 Added 93.69%
4,391 $180,000
Q3 2023

Nov 09, 2023

SELL
$31.13 - $45.99 $13,603 - $20,097
-437 Reduced 16.16%
2,267 $70,000
Q2 2023

Aug 11, 2023

BUY
$33.54 - $49.68 $70,266 - $104,079
2,095 Added 344.01%
2,704 $108,000
Q1 2023

May 12, 2023

BUY
$38.11 - $48.74 $13,490 - $17,253
354 Added 138.82%
609 $25,000
Q4 2022

Feb 08, 2023

BUY
$27.38 - $45.5 $1,505 - $2,502
55 Added 27.5%
255 $11,000
Q3 2022

Nov 10, 2022

SELL
$20.68 - $34.25 $4,280 - $7,089
-207 Reduced 50.86%
200 $6,000
Q2 2022

Aug 10, 2022

BUY
$18.31 - $30.75 $7,452 - $12,515
407 New
407 $8,000
Q1 2022

May 16, 2022

SELL
$20.91 - $30.79 $18,923 - $27,864
-905 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$24.94 - $37.9 $8,230 - $12,507
330 Added 57.39%
905 $27,000
Q3 2021

Nov 15, 2021

BUY
$30.79 - $42.61 $17,704 - $24,500
575 New
575 $20,000
Q1 2021

May 12, 2021

SELL
$28.36 - $45.67 $10,464 - $16,852
-369 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$24.25 - $52.75 $8,948 - $19,464
369 New
369 $18,000

Others Institutions Holding SMTI

About Sanara MedTech Inc.


  • Ticker SMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 8,303,730
  • Market Cap $284M
  • Description
  • Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...
More about SMTI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.